|
|
|
31.08.26 - 11:12
|
Asahi Kasei entwickelt Prä-Lithiierung für Silizium-Anoden (Electrive)
|
|
|
Asahi Kasei hat eine neue Prä-Lithiierungstechnologie für Lithium-Ionen-Batterien mit siliziumhaltigen Anoden entwickelt. In internen Tests will der japanische Konzern damit die Energiedichte einer NMC-Zelle um zehn Prozent gesteigert haben. Nun sollen Tests mit potenziellen Kunden folgen....
|
|
|
|
|
31.07.26 - 07:42
|
Asahi Kasei Corporation Profit Advances In Q1 (AFX)
|
|
|
TOKYO (dpa-AFX) - Asahi Kasei Corporation (AHKSF) revealed earnings for its first quarter that Increased, from last yearThe company's earnings totaled JPY53.766 billion, or JPY39.73 per share. Thi......
|
|
|
20.07.26 - 02:12
|
Huahsu expands capacity to tap AI and advanced packaging demand (Digitimes)
|
|
|
Huahsu, a semiconductor materials supplier established in 1997 through a joint investment by Japan's Asahi Kasei and Wah Lee, has launched a new capacity expansion plan as demand for AI, HPC, and advanced semiconductor packaging accelerates. The company recently held a completion ceremony for its second high-resolution dry film photoresist processing plant....
|
|
|
|
|
|
|
28.05.26 - 17:18
|
Fujitsu, Others Eye Investment in SoftBank-Led AI Firm (Nippon)
|
|
|
Tokyo, May 28 (Jiji Press)--Some Japanese companies, including Fujitsu Ltd. and Asahi Kasei Corp., are considering investing in a new firm established by SoftBank Corp. and others to develop Japanese-made artificial intelligence, it was learned Thursday. The companies are considering a plan to each invest tens of millions of yen, according to informed sources. "I see the value in developi......
|
|
|
21.05.26 - 15:06
|
Ethylene Plant Operating Rate Hits Record Low in Japan (Nippon)
|
|
|
Tokyo, May 21 (Jiji Press)--The ethylene plant operating rate in Japan hit a record low of 67.3 pct in April, the Japan Petrochemical Industry Association said Thursday. "The operating rate has been reduced in order to maintain supplies," Koshiro Kudo, chairman of the association and president of major chemical maker Asahi Kasei Corp., said. Meanwhile, ethylene production in April increa......
|
|
|
|
|
|
|
|
|
21.04.26 - 11:48
|
Asahi Kasei acquires German company Aicuris (PBR)
|
|
|
The move comes after Asahi Kasei signed a definitive agreement to acquire all issued shares of Aicuris for approximately €780m ($920.7m) earlier this year. The acquisition aligns with Asahi Kasei's
The post Asahi Kasei acquires German company Aicuris appeared first on Pharmaceutical Business review....
|
|
|
20.04.26 - 13:36
|
Asahi Kasei Completes Acquisition of Aicuris to Advance Its Global Pharmaceutical Strategy (Business Wire)
|
|
|
Aicuris's three antiviral assets complement Asahi Kasei's therapy portfolio
Aicuris revenue expected to reach $500 million by 2030
FDA has granted Priority Review for the pritelivir New Drug Application. Prescription Drug User Fee Act (PDUFA) target date is Q4 2026
TOKYO--(BUSINESS WIRE)--Asahi Kasei, a diversified global company, announced the successful completion of its acquisition of Aicuris Anti-infective Cures AG (Aicuris), a German-based biopharmaceutical company. This closing marks a key step in accelerating the company's efforts to build a global specialty pharmaceutical platform by expanding further into severe infectious diseases.
“The completion of the Aicuris acquisition reflects the deliberate execution of our pharmaceutical strategy and strengthens our position in infectious diseases, a core area where we see sustained demand, high unmet need, and long-term growth,” stated Ken Shinomiya, Head of Asahi Kasei's Healthcare Sector. “Aicuris adds a differentiated portfolio and scientif...
|
|
|
|
|
|
|
|
|
13.04.26 - 14:03
|
pH7 Technologies Announces Oversubscribed Series B Final Closing and $55M CAD Total Financing Package to Address Global Critical Minerals Shortage (Business Wire)
|
|
|
Backed by global industrial and financial investors, the company has completed its Series B equity financing and secured additional venture debt to strengthen supply chain resilience amid rising geopolitical competitionVANCOUVER, British Columbia--(BUSINESS WIRE)--As global demand for critical minerals accelerates and supply constraints intensify, pH7 Technologies Inc. today announced the oversubscribed final closing of its Series B financing round. The company raised approximately USD ~$32 million in equity, with new backing from Asahi Kasei and the Circular Innovation Fund (CIF), alongside previously announced investors, led by Fine Structure Ventures, with participation from BHP Ventures and continued support from existing investors. The financing comes amid a widening structural gap between demand for metals like copper and the industry's ability to economically extract them from existing resources.
In addition, pH7 has secured venture debt financing from RBCx, bringing the total financing package, i...
|
|
|
02.04.26 - 09:06
|
Asahi Kasei enters AI chip fiberglass market to challenge Nittobo′s dominance (Digitimes)
|
|
|
Japan's Asahi Kasei has announced its official entry into the AI chip supply chain with fiberglass cloth as an insulating substrate material, targeting the current global leader Nittobo, which holds a 90% market share. Meanwhile, Nippon Electric Glass (NEG) also plans to invest in AI-specific fiberglass cloth, signaling accelerated competition among Japanese materials makers for semiconductor opportunities....
|
|
|
|
|
23.03.26 - 15:06
|
Sudden Cardiac Death Risk and Heart Failure Management at ACC.26 – How ZOLL Innovations Redefine Protection (Business Wire)
|
|
|
CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, will highlight the latest sudden cardiac death research, case experiences for heart failure readmission reduction, and two Innovation Stage presentations at the American College of Cardiology Annual Scientific Session & Expo (ACC.26), March 28-30, 2026. ZOLL will sponsor a slate of educational programs to engage and connect clinicians with emerging evidence and evolving practices in cardiac care:
The ACC Innovation Stage will host two ZOLL-sponsored presentations:
A friendly debate about approaches to HFrEF patient management with GDMT, including the LifeVest® wearable cardioverter defibrillator (WCD) as a treatment option.
A case study highlighting a reduction in HF readmission to single digits with the implementation of ZOLL's Heart Failure Management System (HFMS).
ZOLL is sponsoring the ACC Women in Cardiology Mix N' Mingle, as well as events for cardiology fellows an...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
